Invivyd (IVVD) Other Operating Expenses (2021 - 2025)

Invivyd (IVVD) reported Other Operating Expenses of $1.1 million for Q4 2025, up 57.46% on a YoY basis from $724000.0 in Q4 2024, and up 4.78% quarter-over-quarter from $1.1 million in Q3 2025.

Invivyd (IVVD) Other Operating Expenses (2021 - 2025) Analysis & Trends

Invivyd has reported Other Operating Expenses for 5 years, with the latest figure at $1.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 57.46% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.7 million (up 131.58% YoY), and the FY2025 full-year result was $3.7 million, up 131.58% from the prior year.
  • Other Operating Expenses for Q4 2025 stood at $1.1 million, up from $1.1 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $17.8 million in Q4 2022, with the low at -$600000.0 in Q4 2023.
  • Historically, Other Operating Expenses has averaged $2.5 million across 5 years, with a median of $917000.0 in 2021.
  • Annual changes were most pronounced in 2023 — Other Operating Expenses tumbled 103.38% — and 2025, when it surged 678.41%.
  • Invivyd's Other Operating Expenses stood at $4.0 million in 2021, then surged by 344.32% to $17.8 million in 2022, then plunged by 103.38% to -$600000.0 in 2023, then surged by 220.67% to $724000.0 in 2024, then jumped by 57.46% to $1.1 million in 2025.
  • The last three Other Operating Expenses figures came in at $1.1 million (Q4 2025), $1.1 million (Q3 2025), and $685000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Invivyd 168.41 Mn -58.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.09 Mn
Jun 30, 2025 685,000.00
Mar 31, 2025 834,000.00
Dec 31, 2024 724,000.00
Sep 30, 2024 806,000.00
Jun 30, 2024 88,000.00
Dec 31, 2023 -600,000.00
Sep 30, 2023 4.60 Mn
Jun 30, 2023 150,000.00
Mar 31, 2023 825,000.00
Dec 31, 2022 17.77 Mn
Sep 30, 2022 4.00 Mn
Sep 30, 2021 4.00 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 1.00 Mn